| Title |
Publication Date |
Price |
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics
|
March 2010 |
£1495 |
Distribution Agreements in Pharma, Biotech and Diagnostics
2nd edition
|
March 2010 |
£1495 |
Co-Promotion & Co-Marketing Agreements in Pharma, Biotech and Diagnostics
|
February 2010 |
£1495 |
Partnering Agreements with Bigpharma
|
February 2010 |
£1395 |
Nabi Biopharmaceuticals-Deals & Alliances Report
|
January 2010 |
£400 |
Nanogen, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Nektar Therapeutics-Deals & Alliances Report
|
January 2010 |
£400 |
NPS Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Mylan, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Millipore Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Misonix Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Monsanto Co.-Deals & Alliances Report
|
January 2010 |
£400 |
Myriad Genetics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Neoprobe Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
North American Scientific Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Novadel Pharma Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Novartis AG-Deals & Alliances Report
|
January 2010 |
£400 |
Novavax, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
NexMed Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Neurogen Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Micromet, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Neose Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Neurocrine Biosciences Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
NeoPharm, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Merge Healthcare Incorporated.-Deals & Alliances Report
|
January 2010 |
£400 |
MDRNA, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
MDS, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
MZT Holdings, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Martek Biosciences Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Luminex Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Ligand Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Lescarden Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Lexicon Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Life Technologies Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Masimo Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Maxygen, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Mediware Information Systems Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Medtronic, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Merck & Co. Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Nutrition 21 Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Medicis Pharmaceutical Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Medicines Co.-Deals & Alliances Report
|
January 2010 |
£400 |
McKesson Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Medarex, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
MediciNova Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Merit Medical Systems Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Omnicare Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Adolor Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Advanced Cell Technology Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Advanced Life Sciences Holdings, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Advanced Plant Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Adherex Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Adeona Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Accuray Incorporated-Deals & Alliances Report
|
January 2010 |
£400 |
Achillion Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Acorda Therapeutics, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Adventrx Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Aeterna Zentaris Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Alcon Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Alexion Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Alfacell Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Alkermes, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Albany Molecular Research Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Akorn Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Aetna Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Affymetrix Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Air Products & Chemicals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Access Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Accentia Biopharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Opko Health, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Orchid Cellmark Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Orthofix International NV-Deals & Alliances Report
|
January 2010 |
£400 |
Thermogenesis Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Onyx Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Oncothyreon Inc-Deals & Alliances Report
|
January 2010 |
£400 |
OmniComm Systems Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Lannett Co. Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Omnicell Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
ACADIA Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
AMAG Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Abraxis BioScience, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Abviva, Inc-Deals & Alliances Report
|
January 2010 |
£400 |
Accelrys Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Abbott Laboratories-Deals & Alliances Report
|
January 2010 |
£400 |
Abaxis Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
ATS Medical Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
AVI Biopharma, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Aastrom Biosciences, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Nymox Pharmaceutical Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Keryx Biopharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
QLT Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Qiagen NV-Deals & Alliances Report
|
January 2010 |
£400 |
Quadramed Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Questcor Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Progenics Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Procter & Gamble Co.-Deals & Alliances Report
|
January 2010 |
£400 |
PhotoMedex, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Poniard Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Pro-Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Quidel Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Regeneron Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Rochester Medical Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Rosetta Genomics, Ltd.-Deals & Alliances Report
|
January 2010 |
£400 |
SIGA Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Salix Pharmaceuticals Ltd.-Deals & Alliances Report
|
January 2010 |
£400 |
Rigel Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Rexahn Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Repligen Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Repros Therapeutics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
ResMed Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Phase Forward Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Pharmaceutical Product Development Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Oxigene Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
PDL BioPharma, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Pacific Biometrics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Palatin Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Osiris Therapeutics, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
OraSure Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Ardea Biosciences, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
OSI Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
OSI Systems, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Pall Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Palomar Medical Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
PerkinElmer Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Perrigo Co.-Deals & Alliances Report
|
January 2010 |
£400 |
Pfizer Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Peregrine Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Penwest Pharmaceuticals Co.-Deals & Alliances Report
|
January 2010 |
£400 |
Panacos Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Par Pharmaceutical Companies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Parexel International Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Samaritan Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Sangamo Biosciences Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Eli Lilly & Co.-Deals & Alliances Report
|
January 2010 |
£400 |
IR Biosciences Holdings Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
IRIS International Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
ISTA Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
3M Co.-Deals & Alliances Report
|
January 2010 |
£400 |
pSivida Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Zila, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Zimmer Holdings Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
ZymoGenetics, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Insite Vision Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Insmed Incorporated-Deals & Alliances Report
|
January 2010 |
£400 |
Jazz Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Johnson & Johnson-Deals & Alliances Report
|
January 2010 |
£400 |
Allergan Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
King Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Isis Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Intuitive Surgical, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Inspire Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
InterMune Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
International Stem Cell Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
ZOLL Medical Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
XTL Biopharmaceuticals Ltd.-Deals & Alliances Report
|
January 2010 |
£400 |
Senomyx Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Sequenom Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Shire Limited-Deals & Alliances Report
|
January 2010 |
£400 |
Sigma-Aldrich Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Senetek plc-Deals & Alliances Report
|
January 2010 |
£400 |
Senesco Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Santarus Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
SciClone Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Seattle Genetics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Simulations Plus Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Skinvisible Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Sunesis Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
SurModics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Symyx Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Strategic Diagnostics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Stem Cell Innovations, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Smith & Nephew plc-Deals & Alliances Report
|
January 2010 |
£400 |
SonoSite Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Spectrum Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Laboratory Corp. of America Holdings-Deals & Alliances Report
|
January 2010 |
£400 |
MultiCell Technologies, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Osteotech, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Pressure BioSciences, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Pure Bioscience-Deals & Alliances Report
|
January 2010 |
£400 |
Quick-Med Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Oculus Innovative Sciences, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Nxstage Medical, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Let's Talk Recovery, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Manhattan Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Milestone Scientific Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Raptor Pharmaceuticals Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Response Genetics, Inc-Deals & Alliances Report
|
January 2010 |
£400 |
Partnering Agreements with Allergan 2010
|
January 2010 |
£295 |
Partnering Agreements with Amgen 2010
|
January 2010 |
£295 |
Partnering Agreements with Boehringer Ingelheim 2010
|
January 2010 |
£295 |
Partnering Agreements with Alcon 2010
|
January 2010 |
£295 |
Partnering Agreements with Actavis 2010
|
January 2010 |
£295 |
Somanetics Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Sucampo Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Partnering Agreements with Abbott 2010
|
January 2010 |
£295 |
Kensey Nash Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Inovio Biomedical Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Advaxis Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Aethlon Medical Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Radient Pharmaceuticals Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Natus Medical Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Immucor Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Cubist Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
CuraGen Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Curis Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
AMICAS Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
AdvanSource Biomaterials Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Cleveland Biolabs, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Cryo-Cell International Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Impax Laboratories Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Ceragenix Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Celldex Therapeutics, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BioClinica, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BioLife Solutions, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BioSphere Medical Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Partnering Agreements with Astellas 2010
|
January 2010 |
£295 |
Partnering Agreements with AstraZeneca 2010
|
January 2010 |
£295 |
Partnering Agreements with Novo Nordisk 2010
|
January 2010 |
£295 |
Partnering Agreements with Nycomed 2010
|
January 2010 |
£295 |
Partnering Agreements with Otsuka 2010
|
January 2010 |
£295 |
Partnering Agreements with Pfizer 2010
|
January 2010 |
£295 |
Partnering Agreements with Novartis 2010
|
January 2010 |
£295 |
Partnering Agreements with Mylan 2010
|
January 2010 |
£295 |
Partnering Agreements with Merck & Co
2010
|
January 2010 |
£295 |
Partnering Agreements with Merck Serono
2010
|
January 2010 |
£295 |
Partnering Agreements with Mitsubishi Tanabe 2010
|
January 2010 |
£295 |
Partnering Agreements with Ratiopharm 2010
|
January 2010 |
£295 |
Partnering Agreements with Roche 2010
|
January 2010 |
£295 |
Partnering Agreements with Teva 2010
|
January 2010 |
£295 |
Partnering Agreements with UCB 2010
|
January 2010 |
£295 |
Partnering Agreements with Watson 2010
|
January 2010 |
£295 |
Partnering Agreements with Takeda 2010
|
January 2010 |
£295 |
Partnering Agreements with Solvay 2010
|
January 2010 |
£295 |
Partnering Agreements with Sanofi-Aventis 2010
|
January 2010 |
£295 |
Partnering Agreements with Servier 2010
|
January 2010 |
£295 |
Partnering Agreements with Shire 2010
|
January 2010 |
£295 |
Partnering Agreements with Menarini
2010
|
January 2010 |
£295 |
Partnering Agreements with LundBeck
2010
|
January 2010 |
£295 |
Partnering Agreements with Cephalon 2010
|
January 2010 |
£295 |
Partnering Agreements with Chugai 2010
|
January 2010 |
£295 |
Partnering Agreements with Daiichi Sankyo 2010
|
January 2010 |
£295 |
Partnering Agreements with CSL 2010
|
January 2010 |
£295 |
Partnering Agreements with Bristol-Myers Squibb 2010
|
January 2010 |
£295 |
Partnering Agreements with Baxter 2010
|
January 2010 |
£295 |
Partnering Agreements with Bayer 2010
|
January 2010 |
£295 |
Partnering Agreements with Biogen Idec 2010
|
January 2010 |
£295 |
Partnering Agreements with Dainippon Sumitomo 2010
|
January 2010 |
£295 |
Partnering Agreements with Eisai 2010
|
January 2010 |
£295 |
Alliance Pharmaceutical Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Partnering Agreements with Hospira
2010
|
January 2010 |
£295 |
Partnering Agreements with Johnson Johnson
2010
|
January 2010 |
£295 |
Partnering Agreements with Genzyme
2010
|
January 2010 |
£295 |
Partnering Agreements with Genentech
2010
|
January 2010 |
£295 |
Partnering Agreements with Eli Lilly 2010
|
January 2010 |
£295 |
Partnering Agreements with Forest 2010
|
January 2010 |
£295 |
Partnering Agreements with Galxosmithkline
2010
|
January 2010 |
£295 |
Covidien, Ltd.-Deals & Alliances Report
|
January 2010 |
£400 |
Partnering Agreements with Gilead
2010
|
January 2010 |
£295 |
Aspect Medical Systems, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
AstraZeneca plc-Deals & Alliances Report
|
January 2010 |
£400 |
Athersys, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Auxilium Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
ArthroCare Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Arrowhead Research Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Arena Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Ariad Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Array BioPharma, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Avanir Pharmaceuticals-Deals & Alliances Report
|
January 2010 |
£400 |
Averion International Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Bio-Reference Laboratories Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BioCryst Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BioDelivery Sciences International Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BioElectronics Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Beckman Coulter Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Baxter International Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Avigen Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BELLUS Health Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BMP Sunstone Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Aradigm Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
ArQule Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Amarillo Biosciences Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Amarin Corporation plc-Deals & Alliances Report
|
January 2010 |
£400 |
American Medical Systems Holdings Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Amerisourcebergen Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Altus Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Alseres Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Cornerstone Therapeutics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Alpha Innotech Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Alpharx Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Amgen Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Amylin Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Anika Therapeutics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Antares Pharma Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Antigenics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Angiotech Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
AngioDynamics Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Anadys Pharmaceuticals Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Analogic Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Anesiva, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BioForce Nanosciences Holdings, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Avitar Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Cell Genesys, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Celsion Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
BioMarin Pharmaceutical Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Cepheid-Deals & Alliances Report
|
January 2010 |
£400 |
Celgene Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Celera Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Cambrex Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Caraco Pharmaceutical Laboratories Ltd.-Deals & Alliances Report
|
January 2010 |
£400 |
Cardinal Health, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Cerner Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Cerus Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Commonwealth Biotechnologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Compugen Ltd.-Deals & Alliances Report
|
January 2010 |
£400 |
Corgenix Medical Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
CombiMatrix Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Columbia Laboratories Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Charles River Laboratories International Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Clarient, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Clinical Data, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Calypte Biomedical Corp.-Deals & Alliances Report
|
January 2010 |
£400 |
Cephalon Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Biomoda Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Biovail Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Bioheart, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Biomerica Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Bioject Medical Technologies Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Biolase Technology, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Boston Scientific Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Bristol-Myers Squibb Co.-Deals & Alliances Report
|
January 2010 |
£400 |
Alnylam Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BioSante Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Callisto Pharmaceuticals, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
BioTime, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Bruker Corporation-Deals & Alliances Report
|
January 2010 |
£400 |
Biogen Idec Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Caliper Life Sciences, Inc.-Deals & Alliances Report
|
January 2010 |
£400 |
Drug Delivery Partnering Agreements In Pharma & Biotech
|
October 2009 |
£1195 |
Partnering Agreements In Diagnostics
Trends in diagnostics partnering deals Diagnostic partnering agreement structure Diagnostic partnering contract document
|
September 2009 |
£1195 |
Manufacturing & Supply Agreements in Pharma, Biotech and Diagnostics
2nd Edition
|
July 2009 |
£1195 |
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
|
June 2009 |
£1395 |
Practical Guide to Finding Partners in Pharma and Biotech
2nd edition
|
April 2009 |
£695 |
Evolving Trends in Biopharmaceutical Licensing
Deal assessments, drivers and resistors
|
March 2009 |
£2025 |
Option & Evaluation Agreements in Pharma and Biotech
|
March 2009 |
£995 |
Guide to Valuation of Pharmaceutical Licensing Deals
|
February 2009 |
£1500 |
Pharmaceutical Alliance Management
|
December 2008 |
£3990 |
The Royalty Rate Report 2009
A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
|
November 2008 |
£3594 |
Practical Guide to Finding Partners in Biopharma
|
November 2008 |
£495 |
Strategic Alliances in World Pharma and Biotech Markets
|
November 2008 |
£395 |
Product and Asset Purchase Agreements in Pharma, Biotech and Diagnostics
|
November 2008 |
£1195 |
Pre-clinical Stage Partnering Agreements in Biopharma
|
October 2008 |
£1195 |
Discovery Stage Partnering Agreements in Biopharma
|
September 2008 |
£1195 |
Bigpharma Agreements Handbook
Partnering Agreements
|
September 2008 |
£1195 |
Bigpharma Dealmaking Handbook
Companies & Contacts
|
September 2008 |
£1195 |
Mundipharma Partnering Guide 2008
|
July 2008 |
£195 |
Abbott Labs Partnering Guide 2008
|
July 2008 |
£195 |
Alcon Labs Partnering Guide 2008
|
July 2008 |
£195 |
Actavis Pharma Partnering Guide 2008
|
July 2008 |
£195 |
Allergan Partnering Guide 2008
|
July 2008 |
£195 |
Barr Pharmaceuticals Partnering Guide 2008
|
July 2008 |
£195 |
Stada Partnering Guide 2008
|
July 2008 |
£195 |
ScheringPlough Partnering Guide 2008
|
July 2008 |
£195 |
Wyeth Partnering Guide 2008
|
July 2008 |
£195 |
ProcterGamble Partnering Guide 2008
|
July 2008 |
£195 |
King Partnering Guide 2008
|
July 2008 |
£195 |
GlaxoSmithKline Partnering Guide 2008
|
July 2008 |
£195 |
Amgen Partnering Guide 2008
|
July 2008 |
£195 |
Clinical Stage Partnering Agreements in Biopharma
|
June 2008 |
£1295 |
Emerging Pharmaceutical Markets Globally
|
April 2008 |
£1000 |
Bigpharma Partnering Agreements
|
March 2008 |
£1195 |
Stem Cell Innovations, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
StemCells Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Stryker Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Sunesis Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Stellar Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Strategic Diagnostics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
SpectRx Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Sonus Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
SuperGen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Spectrum Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
St. Jude Medical Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Starpharma Holdings Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Synvista Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Taro Pharmaceutical Industries Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Techne Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Teleflex Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Telik Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Targeted Genetics Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Tapestry Pharmaceuticals -Deals & Alliances Report
|
February 2008 |
£200 |
Sygnis Pharma AG -Deals & Alliances Report
|
February 2008 |
£200 |
Symyx Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Syngenta AG -Deals & Alliances Report
|
February 2008 |
£200 |
SonoSite Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
SurModics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Sigma -Aldrich Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Santarus Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Sanofi -Aventis -Deals & Alliances Report
|
February 2008 |
£200 |
Savient Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Schering -Plough Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Schwarz Pharma AG -Deals & Alliances Report
|
February 2008 |
£200 |
Sangamo Biosciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Samaritan Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
SGX Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
SIGA Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Safeguard Scientifics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Salix Pharmaceuticals Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Sciele Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Seattle Genetics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Tenet Healthcare Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Siemens AG -Deals & Alliances Report
|
February 2008 |
£200 |
Simulations Plus Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Skinvisible Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
SkyePharma plc -Deals & Alliances Report
|
February 2008 |
£200 |
Shire plc -Deals & Alliances Report
|
February 2008 |
£200 |
SeraCare Life Sciences Inc. Del -Deals & Alliances Report
|
February 2008 |
£200 |
Senesco Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Senomyx Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Sepracor, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Sequenom Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Smith & Nephew plc -Deals & Alliances Report
|
February 2008 |
£200 |
Third Wave Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Waters Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Warner Chilcott Limited -Deals & Alliances Report
|
February 2008 |
£200 |
inVentiv Health, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Watson Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
WellPoint Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Volcano Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Vital Images Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
VioQuest Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Vion Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Viragen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
ViroPharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
West Pharmaceutical Services Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Women First Healthcare Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Zila, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Zimmer Holdings Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
ZymoGenetics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Rosetta Genomics, Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
ZOLL Medical Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
YM BioSciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Wright Medical Group Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Wyeth -Deals & Alliances Report
|
February 2008 |
£200 |
XOMA Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
XTL Biopharmaceuticals Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Vical Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Vertex Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Trinity Biotech plc -Deals & Alliances Report
|
February 2008 |
£200 |
Transgenomic Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Tripos Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Tyco International Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Unigene Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
TorreyPines Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Titan Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Theragenics Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Thermo Fisher Scientific, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Thermogenesis Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Thomson Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Unilever NV -Deals & Alliances Report
|
February 2008 |
£200 |
United Therapeutics Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Ventana Medical Systems Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Verenium Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Vermillion, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Vernalis plc -Deals & Alliances Report
|
February 2008 |
£200 |
VaxGen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Varian Medical Systems Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Unitedhealth Group, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Utek Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
VIA Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Valeant Pharmaceuticals International -Deals & Alliances Report
|
February 2008 |
£200 |
Teva Pharmaceutical Industries Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Roche Holding AG -Deals & Alliances Report
|
February 2008 |
£200 |
Commonwealth Biotechnologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
CombinatoRx Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Competitive Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Compugen Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Consort Medical plc. -Deals & Alliances Report
|
February 2008 |
£200 |
CombiMatrix Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Columbia Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Chugai Pharmaceutical Co. Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Chembio Diagnostics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Clarient, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Clinical Data, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
CollaGenex Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Corgenix Medical Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Corning Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cypress Bioscience Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cyclacel Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
CytRx Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
CytoCore, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cytogen Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Curis Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
CuraGen Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Critical Therapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Covance Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Crucell NV -Deals & Alliances Report
|
February 2008 |
£200 |
CryoLife Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cubist Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Charles River Laboratories International Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cerus Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Caraco Pharmaceutical Laboratories Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Cambrex Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Cardiac Science Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Cardinal Health Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
CardioDynamics International Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Calypte Biomedical Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Caliper Life Sciences, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
CEL -SCI Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Bruker BioSciences Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
CIBA Specialty Chemicals Holding, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
CR Bard Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
CV Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cardiome Pharma Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Carrington Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cenes Pharmaceuticals plc -Deals & Alliances Report
|
February 2008 |
£200 |
Celsion Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Cephalon Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cepheid -Deals & Alliances Report
|
February 2008 |
£200 |
Cerner Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Cellegy Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cell Therapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Ceapro Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Celera Group -Deals & Alliances Report
|
February 2008 |
£200 |
Celgene Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Cell Genesys, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cytogenix Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Cytori Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
EpiCept Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Enzon Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Epigenomics AG -Deals & Alliances Report
|
February 2008 |
£200 |
Eurand N.V. -Deals & Alliances Report
|
February 2008 |
£200 |
Exelixis Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Enzo Biochem Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
EntreMed Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Endo Pharmaceuticals Holdings Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Encysive Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Endologix Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Endovasc Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Enhance Biotech Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Rohm & Haas Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Flamel Technologies SA -Deals & Alliances Report
|
February 2008 |
£200 |
GenVec Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Gen -Probe Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Genaera Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Genelabs Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Genentech Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Gedeon Richter Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
GTC Biotherapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Forbes Medi Tech Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Forest Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Fresenius Medical Care AG & Co. KGAA -Deals & Alliances Report
|
February 2008 |
£200 |
GPC Biotech AG -Deals & Alliances Report
|
February 2008 |
£200 |
Encorium Group Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Emisphere Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Derma Sciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
DepoMed Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Discovery Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Dow Chemical Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Draxis Health Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Dendreon Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Deltagen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
DNAprint Genomics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
DATATRAK International, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
DOR BioPharma, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
DUSA Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Daxor Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Durect Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Dyax Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Elan Corp. plc -Deals & Alliances Report
|
February 2008 |
£200 |
Eisai Co. Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Elite Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Emageon Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Emergent BioSolutions, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Edwards Lifesciences Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Eastman Kodak Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Dynavax Technologies Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
EI DuPont de Nemours & Co. -Deals & Alliances Report
|
February 2008 |
£200 |
EPIX Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
EXACT Sciences Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Bristol -Myers Squibb Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Bradley Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Alliance Pharmaceutical Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Allergan Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Alltracel Pharmaceuticals plc. -Deals & Alliances Report
|
February 2008 |
£200 |
Alnylam Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Alpha Innotech Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Alkermes, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Alfacell Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Albany Molecular Research Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Akzo Nobel NV -Deals & Alliances Report
|
February 2008 |
£200 |
Alchemia Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Alcon Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Alexion Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Alpharma, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Alpharx Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Anesiva, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Anadys Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
AngioDynamics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Angiotech Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Anika Therapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Amylin Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Amgen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Altana AG -Deals & Alliances Report
|
February 2008 |
£200 |
Alseres Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Amarillo Biosciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
American Medical Systems Holdings Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Amerisourcebergen Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Akorn Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Air Products & Chemicals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Acambis plc -Deals & Alliances Report
|
February 2008 |
£200 |
Acadia Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Accelrys Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Accentia Biopharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Access Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Acacia Research Corp. - Acacia Technologies -Deals & Alliances Report
|
February 2008 |
£200 |
Abbott Laboratories -Deals & Alliances Report
|
February 2008 |
£200 |
AVANT Immunotherapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
AMAG Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
AVI Biopharma, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Aastrom Biosciences, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Abaxis Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Accuray Incorporated -Deals & Alliances Report
|
February 2008 |
£200 |
Acorda Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Aeterna Zentaris, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Adventrx Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Aetna Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Affymetrix Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Agenix Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Advanced Tissue Sciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Advanced Plant Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Actelion Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Adolor Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Advanced Cell Technology Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Advanced Medical Optics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Antares Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Antigenics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
BioCryst Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Bio -Reference Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
BioDelivery Sciences International Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
BioElectronics Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
BioForce Nanosciences Holdings, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Bentley Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Benitec Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Bayer AG -Deals & Alliances Report
|
February 2008 |
£200 |
Baxter International Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Beckman Coulter Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Becton Dickinson & Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Bell Microproducts Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
BioMarin Pharmaceutical Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
BioSante Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Biosyntech Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Biophage Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Biotech Holdings Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Biovail Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Boston Scientific Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Bioniche Life Sciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Biomerica Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Biocon Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Biogen Idec Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Bioject Medical Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Biolase Technology Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Barrier Therapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Barr Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Array BioPharma, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Ariad Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Arrowhead Research Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Arthrocare Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Aspect Medical Systems, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Arena Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Arana Therapeutics Limited -Deals & Alliances Report
|
February 2008 |
£200 |
Aphton Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Antisoma plc -Deals & Alliances Report
|
February 2008 |
£200 |
Applera Corp -Applied Biosystems Group -Deals & Alliances Report
|
February 2008 |
£200 |
ArQule Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Aradigm Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Aspen Technology Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Astellas Pharma, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Avigen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Averion International Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Avitar Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Axcan Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
BASF SE -Deals & Alliances Report
|
February 2008 |
£200 |
Avanir Pharmaceuticals -Deals & Alliances Report
|
February 2008 |
£200 |
Avalon Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
AstraZeneca plc -Deals & Alliances Report
|
February 2008 |
£200 |
Athersys, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Auriga Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Auxilium Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
General Electric Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Express Scripts Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
North American Scientific Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
NitroMed Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Novadel Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Novartis AG -Deals & Alliances Report
|
February 2008 |
£200 |
Novavax, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
NexMed Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Neurogen Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Neose Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Neoprobe Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Nestle SA -Deals & Alliances Report
|
February 2008 |
£200 |
Neurochem Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Neurocrine Biosciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Noven Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Novo Nordisk A -Deals & Alliances Report
|
February 2008 |
£200 |
Oncothyreon Inc -Deals & Alliances Report
|
February 2008 |
£200 |
Omnicell Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Onyx Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Opko Health, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
OraSure Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Omnicare Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
OSI Systems, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Nutrition 21 Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Novozymes A -Deals & Alliances Report
|
February 2008 |
£200 |
Nuvelo Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Nymox Pharmaceutical Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
OSI Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
NeoPharm Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Nektar Therapeutics -Deals & Alliances Report
|
February 2008 |
£200 |
Micromet, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Merit Medical Systems Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Microsoft Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Migenix Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Millennium Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Meridian Bioscience Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Merge Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Medtronic Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Mediware Information Systems Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Meldex International Plc -Deals & Alliances Report
|
February 2008 |
£200 |
Mentor Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Merck & Co. Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Millipore Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Generex Biotechnology Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
NPS Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Myriad Genetics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Nabi Biopharmaceuticals -Deals & Alliances Report
|
February 2008 |
£200 |
Nanogen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Nastech Pharmaceutical Company, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Mylan, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
MultiCell Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Mitsui & Co. Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Monogram Biosciences, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Monsanto Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Motorola Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Oracle Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Orchid Cellmark Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
QLT Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Psivida Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Qiagen NV -Deals & Alliances Report
|
February 2008 |
£200 |
Quadramed Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Questcor Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Protherics plc -Deals & Alliances Report
|
February 2008 |
£200 |
Proteome Sciences plc -Deals & Alliances Report
|
February 2008 |
£200 |
Pro -Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Pressure BioSciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Procter & Gamble Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Progen Pharmaceuticals Limited -Deals & Alliances Report
|
February 2008 |
£200 |
Progenics Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Quidel Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Regeneration Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Rexahn Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Response Biomedical Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Rigel Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Rochester Medical Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Rockwell Automation Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Respironics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
ResMed Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Regeneron Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Renovis Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Repligen Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Repros Therapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Poniard Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Pipex Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Palatin Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Pacific Biometrics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Pall Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Panacos Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Par Pharmaceutical Companies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
PDL BioPharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
PDI Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Orthovita Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Orthofix International NV -Deals & Alliances Report
|
February 2008 |
£200 |
Oscient Pharmaceuticals Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Osiris Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Osteotech Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Parexel International Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Penwest Pharmaceuticals Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Pharming Group N.V. -Deals & Alliances Report
|
February 2008 |
£200 |
Pharmasset, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Pharsight Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Phase Forward Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Phytopharm plc -Deals & Alliances Report
|
February 2008 |
£200 |
Pharmacopeia, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Pharmaceutical Product Development Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Peregrine Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
PerkinElmer Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Perrigo Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Pfizer Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Medicure Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Misonix Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Implant Sciences Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Immunomedics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Incyte Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Indevus Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Medicis Pharmaceutical Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Immunogen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Immunicon Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Imclone Systems Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Imarx Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Immtech Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
ImmuCell Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Immucor Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Integrated Biopharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Interleukin Genetics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
The Cooper Companies Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Spectral Diagnostics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
deCODE genetics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
eResearchTechnology Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
etrials Worldwide, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
SCOLR Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Quest Diagnostics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
International Business Machines Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Inverness Medical Innovations Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Labopharm Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Natus Medical Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Illumina Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Idera Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Haemonetics Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
HLTH Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Healthways Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Helix Biomedix Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Hemispherx Biopharma, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
H. Lundbeck A -Deals & Alliances Report
|
February 2008 |
£200 |
Glaxosmithkline plc -Deals & Alliances Report
|
February 2008 |
£200 |
Genta Incorporated -Deals & Alliances Report
|
February 2008 |
£200 |
Genetic Technologies Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Genzyme Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Geron Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
Gilead Sciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Henry Schein Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Heska Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
ICAgen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Humana Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
IDEXX Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
IDM Pharma, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
IGI Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Human Genome Sciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Hospira Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Hewlett -Packard Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Hi Tech Pharmacal Co. Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Hitachi Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Hologic Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
icad Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Integra LifeSciences Holdings Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Let's Talk Recovery, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Lescarden Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Lexicon Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Life Therapeutics Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
LifeCell Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Large Scale Biology Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Lannett Co. Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
King Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Keryx Biopharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Koninklijke Philips Electronics NV -Deals & Alliances Report
|
February 2008 |
£200 |
Kosan Biosciences Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Laboratory Corp. of America Holdings -Deals & Alliances Report
|
February 2008 |
£200 |
Lifecore Biomedical Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Ligand Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Medarex Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
McKesson Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
MedcoHealth Solutions Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
MediciNova Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Medicines Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Maxygen Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Masimo Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
3M Co. -Deals & Alliances Report
|
February 2008 |
£200 |
MDS, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
MGI Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Martek Biosciences Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
KV Pharmaceutical Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Luminex Corporation -Deals & Alliances Report
|
February 2008 |
£200 |
ISIS Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
IRIS International Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
ISTA Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Impax Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
InNexus Biotechnology, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
IMS Health Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Eli Lilly & Co. -Deals & Alliances Report
|
February 2008 |
£200 |
Allscripts Healthcare Solutions Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Bayer Schering Pharma AG -Deals & Alliances Report
|
February 2008 |
£200 |
Callisto Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Dr. Reddy's Laboratories Ltd. -Deals & Alliances Report
|
February 2008 |
£200 |
Johnson & Johnson -Deals & Alliances Report
|
February 2008 |
£200 |
Infinity Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Intuitive Surgical, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Introgen Therapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Invitrogen Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Inyx Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Jazz Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
InterMune Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Inspire Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Inhibitex Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Inflazyme Pharmaceuticals Ltd -Deals & Alliances Report
|
February 2008 |
£200 |
Insite Vision Inc. -Deals & Alliances Report
|
February 2008 |
£200 |
Insmed Incorporated -Deals & Alliances Report
|
February 2008 |
£200 |
Inovio Biomedical Corp. -Deals & Alliances Report
|
February 2008 |
£200 |
Accelerate M&A Success
Making Integration Work
|
December 2007 |
£4655 |
Corporate Security
Protecting Productivity
|
December 2007 |
£4655 |
Crisis Management And Corporate Reputation
Counter-Generics Strategy, Tactics and Execution
|
November 2007 |
£4655 |
Bigpharma Dealmaking and Agreements Handbook 2007
Companies, Contacts & Partnering Agreements
|
September 2007 |
£1195 |
The Licensing Agreement in Pharmaceutical Business Development
3rd edition
|
July 2007 |
£450 |
Licensing Agreement in Pharmaceutical Business Development, The
3rd Edition
|
July 2007 |
£700 |
Pricing and Reimbursement Risk and Opportunity in Pharmaceutical Deal Making
|
May 2007 |
£1695 |
Early Stage and Discovery Deals
Strategy, Structure and Payment Terms 2nd Edition
|
December 2006 |
£1880 |
Structuring Patent Licensing Transactions
Leading Lawyers on Structuring Terms, Negotiating License Agreements, and Closing Deals
|
December 2006 |
£50 |
Specialty Pharma Market Outlook, The
Key players, new company growth models and emerging opportunities
|
October 2006 |
£1495 |
Pharmaceutical Strategic Alliances
Maximizing returns from collaborative development and commercialization
|
September 2006 |
£1495 |
Enzymes
US industry forecasts to 2010 & 2015
|
July 2006 |
£2860 |
Effective Licensing & Commercialisation of Drug Delivery Systems
2006
|
July 2006 |
£2500 |
Mid Pharma Sector
In-licensing and other externalization strategies
|
June 2006 |
£2895 |
Pharmaceutical Licensing Strategies
Best practices in deal-making, valuations and strategic management
|
June 2006 |
£1495 |
Partneringdesk deals and alliances in cardiovascular diseases
|
April 2006 |
£1250 |
Partneringdesk deals and alliances in gastrointestinal diseases
|
April 2006 |
£1250 |
Partneringdesk deals and alliances in autoimmune & inflammatory diseases
|
April 2006 |
£1250 |
Partneringdesk Deals and alliances in infectious diseases
Duplication
|
April 2006 |
£1250 |
Partneringdesk deals and alliances in musculoskeletal diseases
|
April 2006 |
£1250 |
Partneringdesk deals and alliances in blood and lymphatic diseases
|
April 2006 |
£1250 |
Partneringdesk deals and alliances in genitourinary and gynecological diseases
|
April 2006 |
£1250 |
Partneringdesk deals and alliances in sensory and dental diseases
|
April 2006 |
£1250 |
Lifecycle Management Strategies
Maximizing ROI through indication expansion, reformulation and Rx-to-OTC switching
|
January 2006 |
£1495 |
Active Pharmaceutical Ingredients
|
May 2005 |
£80 |
Wipes to 2009
|
March 2005 |
£2730 |
Medical Plastics to 2008
|
January 2005 |
£2730 |
Pharmaceutical Product Strategy
Using Dynamic Modeling for Effective Brand Planning
|
December 2004 |
£90 |
The Handbook on Alliances & Deals in Biotech Business
|
May 2004 |
£450 |
